High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain
Javier Crespo1,
, Moisés Diago2, Joaquín Cabezas1, Marina Berenguer3, Teresa Broquetas4, Miguel Ángel Serra5, Rosa Morillas6, Javier García-Samaniego7, José Luis Calleja8, Juan José Sánchez9, Sabela Lens10, Susana Soto-Fernández11, Begoña Sacristán12, Inmaculada Fernández13, Carmen López-Núñez14, María Buti15, Manuel Romero-Gómez16, Federico Sáez-Royuela17, Conrado Fernández18, Francisco Jorquera19..., Gloria Sánchez-Antolín20, Juan Manuel Pascasio21, Antonio Cuadrado22, Manuel Hernández-Guerra23, Spanish F2-Group Ver más
Corresponding author
1 Hospital Universitario Marqués de Valdecilla and IDIVAL. Santander. Spain
2 Hospital General Valencia. Spain
3 Hospital La Fé, University of Valencia and CIBERehd. Spain
4 Hospital Universitario del Mar. Barcelona. Spain
5 Hospital Clínico Universitario-Universidad de Valencia. Valencia. Spain
6 Hospital Universitario Trías y Pujol and CIBERehd. Badalona. Spain
7 Hospital Carlos III and CIBERehd. Madrid. Spain
8 Hospital Universitario Puerta Hierro. Madrid. Spain
9 Hospital Toledo. Spain
10 Hospital Clinic, IDIBAPS and CIBERehd. Barcelona. Spain
11 Hospital del Tajo, Aranjuez, Madrid. Spain
12 Hospital San Pedro, Logroño. Spain
13 Hospital 12 de Octubre. Madrid. Spain
14 Hospital Universitario Girona Dr. Josep Trueta. Spain
15 Hospital Universitario del Vall d’Hebrón and CIEBRehd. Barcelona. Spain
16 Hospital Universitario Valme and CIBERehd. Sevilla. Spain
17 Hospital Universitario de Burgos. Spain
18 Hospital Universitario de Alcorcón. Spain
19 Complejo Asistencial Universitario León. Spain
20 Hospital Universitario Rio Hortega. Valladolid. Spain
21 Hospital Universitario Virgen del Rocío. Sevilla. Spain
22 Hospital Comarcal de Laredo. Spain
23 Hospital Universitario de Canarias. Tenerife. Spain
Ver másRead
1755
Timeswas read the article
580
Total PDF
1175
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 127 | 6 | 133 |
| 2025 11 | 24 | 45 | 69 |
| 2025 10 | 13 | 23 | 36 |
| 2025 9 | 23 | 16 | 39 |
| 2025 8 | 29 | 14 | 43 |
| 2025 7 | 44 | 8 | 52 |
| 2025 6 | 22 | 7 | 29 |
| 2025 5 | 16 | 3 | 19 |
| 2025 4 | 17 | 1 | 18 |
| 2025 3 | 21 | 2 | 23 |
| 2025 2 | 43 | 5 | 48 |
| 2025 1 | 22 | 2 | 24 |
| 2024 12 | 20 | 3 | 23 |
| 2024 11 | 24 | 5 | 29 |
| 2024 10 | 5 | 8 | 13 |
| 2024 9 | 12 | 11 | 23 |
| 2024 8 | 10 | 12 | 22 |
| 2024 7 | 8 | 4 | 12 |
| 2024 6 | 20 | 7 | 27 |
| 2024 5 | 17 | 4 | 21 |
| 2024 4 | 10 | 3 | 13 |
| 2024 3 | 15 | 3 | 18 |
| 2024 2 | 10 | 5 | 15 |
| 2024 1 | 4 | 3 | 7 |
| 2023 12 | 7 | 11 | 18 |
| 2023 11 | 7 | 19 | 26 |
| 2023 10 | 11 | 16 | 27 |
| 2023 9 | 3 | 14 | 17 |
| 2023 8 | 15 | 12 | 27 |
| 2023 7 | 3 | 7 | 10 |
| 2023 6 | 14 | 4 | 18 |
| 2023 5 | 34 | 9 | 43 |
| 2023 4 | 36 | 14 | 50 |
| 2023 3 | 28 | 12 | 40 |
| 2023 2 | 29 | 4 | 33 |
| 2023 1 | 3 | 8 | 11 |
| 2022 12 | 7 | 1 | 8 |
| 2022 11 | 14 | 3 | 17 |
| 2022 10 | 18 | 10 | 28 |
| 2022 9 | 14 | 4 | 18 |
| 2022 8 | 7 | 5 | 12 |
| 2022 7 | 10 | 10 | 20 |
| 2022 6 | 10 | 7 | 17 |
| 2022 5 | 9 | 7 | 16 |
| 2022 4 | 10 | 9 | 19 |
| 2022 3 | 7 | 8 | 15 |
| 2022 2 | 9 | 5 | 14 |
| 2022 1 | 12 | 6 | 18 |
| 2021 12 | 11 | 6 | 17 |
| 2021 11 | 18 | 12 | 30 |
| 2021 10 | 32 | 12 | 44 |
| 2021 9 | 25 | 8 | 33 |
| 2021 8 | 10 | 9 | 19 |
| 2021 7 | 7 | 6 | 13 |
| 2021 6 | 11 | 10 | 21 |
| 2021 5 | 9 | 8 | 17 |
| 2021 4 | 35 | 11 | 46 |
| 2021 3 | 14 | 6 | 20 |
| 2021 2 | 8 | 6 | 14 |
| 2021 1 | 9 | 11 | 20 |
| 2020 12 | 6 | 2 | 8 |
| 2020 11 | 10 | 8 | 18 |
| 2020 10 | 16 | 5 | 21 |
| 2020 9 | 10 | 4 | 14 |
| 2020 8 | 9 | 9 | 18 |
| 2020 7 | 6 | 6 | 12 |
| 2020 6 | 6 | 0 | 6 |
| 2020 5 | 5 | 4 | 9 |
| 2020 4 | 4 | 2 | 6 |
| 2020 3 | 4 | 1 | 5 |
| 2020 2 | 7 | 2 | 9 |
| 2020 1 | 11 | 2 | 13 |
| 2019 12 | 8 | 8 | 16 |
| 2019 11 | 3 | 3 | 6 |
| 2019 10 | 2 | 0 | 2 |
| 2019 9 | 1 | 1 | 2 |
| 2019 8 | 1 | 2 | 3 |
| 2019 7 | 2 | 5 | 7 |
| 2019 6 | 2 | 6 | 8 |
Show all
